1. Introduction {#sec1}
===============

Hypertension is a common cause of cardiovascular diseases and major cause of morbidity and mortality because of its association with arteriosclerosis, coronary heart disease, stroke, myocardial infarction, cerebrovascular diseases, and renal disease.[@bib1], [@bib2], [@bib3] The cardiovascular system can affect a variety of mechanism including, environment pollutants. Cadmium (Cd^2+^) is an environmental toxicant, exposure to human via industrial contamination, food sources and tobacco smoke.[@bib4] Cd^2+^ exposure can affect several organs such as liver, kidneys, eyes, reproductive system and cardiovascular system.[@bib5], [@bib6], [@bib7], [@bib8] Increased oxidative stress during Cd^2+^ toxicity can affect the vascular wall and myocardial tissues, thereby leading to hypertension and cardiotoxicity.[@bib5] Literature survey revealed that cardiovascular system is a critical target of Cd^2+^ toxicity, leading to an increased risk of cardiovascular disease.[@bib9], [@bib10] Moreover, epidemiological studies demonstrate a positive association between hypertension and blood Cd2+ level.[@bib11], [@bib12] Plethora of literatures illustrate that Cd^2+^ exposure can affect the availability of vasodilator nitric oxide, oxidative defense system, renin angiotensin system, and calcium associated contractile activity in the cardiovascular system. These various mechanisms are involved in the development of hypertension and cardiotoxicity.[@bib5], [@bib13], [@bib14], [@bib15], [@bib16] Enhanced oxidative stress in the heart, vascular wall, and kidney is the characteristic feature of cardiovascular diseases.[@bib17] Numerous studies indicate that antioxidants and nutrition supplements may improve the cardiovascular health. Antioxidants scavenge free radicals and regulate gene expression and signaling regulatory pathways, consequently prevent cell death.[@bib18] Among the pharmacological treatments, various studies concerning lifestyle change with the regular physical activity and nutritional supplements may improve the cardiovascular health.

Observational studies suggest that magnesium ion (Mg^2+^) and taurine have potential nutritional value for regulation of hypertension and cardiovascular physiology.[@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24] Mg^2+^ is the second most abundant intracellular ion and regulates various biological activity in the cardiovascular system.[@bib19] Mg^2+^ modulates the production and release of nitric oxide, improve the endothelial dependent vasodilation, inhibits the Ca^2+^ influx, and activates the Ca^2+^ATPase and Na^+^K^+^ATPase resulting in the alteration of arterial smooth muscle tone, and blood pressure. Moreover, reduced extracellular Mg^2+^ trigger the Ca^2+^ influx by Ca^2+^ channels and activates inositol-triphosphate (IP-3) mediated mobilization of intracellular Ca^2+^.[@bib19], [@bib20], [@bib25], [@bib26] Taurine (2-aminoethanesulphonic acid) is the most abundant, semi-essential, sulfur-containing amino acid, which can be derived in the body from diet and synthesized from the cysteine amino acid.[@bib27] Taurine supplementation has shown several potential beneficial effects on cardiovascular system. It regulates the endothelial function, nitric oxide production, renin-angiotensin system, oxidative stress system, and sympathoadrenal system.[@bib21], [@bib23], [@bib24], [@bib27] Moreover, depletion of Mg^2+^ and taurine can accelerate the development of hypertension.[@bib28], [@bib29] Therefore, magnesium taurate (MgT), a complex of Mg^2+^ and taurine ([Fig. 1](#fig1){ref-type="fig"}) may ameliorate the hypertension and cardioprotective effects. In this perceptive, we investigated the possible antihypertensive and cardioprotective effects of MgT against the CdCl~2~-induced hypertension in rat as an experimental model.Fig. 1The molecular structure of magnesium taurate.Fig. 1

2. Material and methods {#sec2}
=======================

2.1. Drugs and dosing {#sec2.1}
---------------------

Magnesium taurate was purchased from Cardiovascular research limited, California. CdCl~2~ was purchased from Himedia Chemicals, Mumbai, India. Other chemicals and reagents used were of analytical grade. A stock solution of MgT (2 mg/ml) and amlodipine (3 mg/ml) was prepared by suspending in 0.3% w/v solution of carboxymethyl cellulose solution as the vehicle and administered by the oral route according to their dose. Stock solution of MgT (2 ml/kg) was administerd orally at two doses level 1 ml/kg/day for 2 mg/kg/day and 2 ml/kg/day for 4 mg/kg/day in their respective group. Stock solution of amlodipine (3 mg/ml) was administerd orally at 1 ml/kg for 3 mg/kg/day dose. A stock solution (0.5 ml/kg) of CdCl~2~ was prepared by dissolving in distilled water and administered via intraperitoneal route (0.5 ml/kg/day). The effective doses of the drugs CdCl~2~, MgT, and amlodipine were selected based on the previous reports.[@bib30], [@bib31], [@bib32] All the doses were administered daily during 10:00 am to 11:00 am.

2.2. Animals {#sec2.2}
------------

Sprague Dawley male albino rats (120--150 g, 12--15 weeks old) were used in the present study. They were housed under standard environmental condition (22 ± 2 °C, with 55 ± 5% humidity and 12 h light/dark cycle), in accordance with the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and Forests, Govt. of India. Animals were allowed to have free access to standard pellet diet with water *ad-libitum* under hygienic conditions. The whole experimental protocol was approved by the Institutional Animals Ethics Committee (Reg. NO.- 994/GO/ERe/S/06/CPCSEA) of Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur (C.G.) India and the experiments on animals were conducted as per the ethical principles and guidelines provided by CPCSEA, Govt. of India.

2.3. Experimental design {#sec2.3}
------------------------

The albino rats, which were normal regarding the blood pressure examination at the baseline after an acclimatization period of seven days, were selected for the present study. The selected animals were divided into five groups having six animals in each group. Group I (normal) animals received 0.3% carboxymethyl cellulose (10 ml/kg/day, p.o.) for four weeks. Hypertension was induced in groups II to V by administration of CdCl~2~ (0.5 mg/kg/day, i.p.) for four weeks.[@bib33] By the end of the second week, induction of hypertension was observed in all the animals of groups II to V. After induction of hypertension, group II (toxic control) continued to receive CdCl~2~ only, while group III (standard) received amlodipine (3 mg/kg/day, p.o.) and group IV to V received MgT at two dose levels (2 and 4 mg/kg/day, p.o.) respectively, concurrently with CdCl~2~ from the beginning of the third week to fourth week.

2.4. Measurement of blood pressure and heart rate {#sec2.4}
-------------------------------------------------

The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were monitored biweekly by using non-invasive blood pressure system (CODA-08 Channel, Kent scientific, USA).

2.5. Preparation of heart homogenate {#sec2.5}
------------------------------------

Animals were sacrificed after completion of experimental protocol (four weeks). The hearts were isolated and washed with cold saline. Each heart was homogenized in 10% w/v of 0.1 M potassium phosphate buffer (pH 7.4). The homogenate was centrifuged at 10,000 rpm for 1 h. The supernatant was separated and stored at 2--8 °C for further biochemical analysis.[@bib34]

2.6. Cardiac biochemical assay {#sec2.6}
------------------------------

Enzymatic antioxidants such as glutathione peroxidase (GPx) was assayed by using method of Tappel (1978),[@bib35] catalase (CAT) activity was determined by using method of Sinha, (1972),[@bib36] and superoxide dismutase (SOD) was measured by using method of Kakkar *et al.* (1984).[@bib37] Non-enzymatic antioxidant, reduced glutathione (GSH) was estimated by using Ellman\'s reagent.[@bib38] Malondialdehyde (MDA), an end product of lipid peroxidation was estimated in the heart homogenate by colorimetric methods of Ohkawa, (1979).[@bib39]

2.7. Histopathological examination of heart {#sec2.7}
-------------------------------------------

One heart from the each group was fixed in 10% buffered neutral formalin solution. After fixation, tissue was embedded in paraffin wax, cut about 5 μm, and mounted on slides, stained with hematoxylin and eosin (H&E). The slides were viewed under a trinocular microscope (AXIOCAM-ERC-5S, Germany) at various magnifications (10x and 40x) to find out the changes in the microscopic features of tissues under study. The myocardial damage was scored depending upon myocardial damages.[@bib40] Score 00: normal (no changes), score 01: mild (focal myocyte damage with mild degree of inflammation), score 02: moderate (degeneration in cardiac muscle fibres), score 03: marked (complete loss of cross striation, loss of cardiomyocyte boundary, degeneration in cardiac muscle fibres, necrosis, vacuolization, edematous fluid, fatty degeneration and infiltration of inflammatory cells).

2.8. Statistical analysis {#sec2.8}
-------------------------

All tested data were expressed as mean ± SEM. Assessments of results were performed using analysis of variance (ANOVA). The level of statistical significance was set at *P \< 0.05*. Statistical analysis was performed using GraphPad Prism version 5.0 (Graph pad Software Inc., CA. USA).

3. Results {#sec3}
==========

3.1. Effect on blood pressure {#sec3.1}
-----------------------------

The CdCl~2~-treated rats (Groups II to V) showed significant (*P \< 0.001*) elevation in blood pressure in terms of SBP and DBP within two weeks as compared to the normal group ([Fig. 2](#fig2){ref-type="fig"}). The Group II (toxic control) showed significant (*P \< 0.001*) induction of hypertension in a time dependent manner (day zero to fourth week) as compared to the normal group. Whereas, the next two weeks (third to four weeks) oral administration of amlodipine (3 mg/kg) in group III (standard) and MgT in groups IV and V at 2 and 4 mg/kg led to significant (*P \< 0.001*) reduction in the blood pressures as compared to toxic control group. The results indicate that MgT at 4 mg/kg has profound antihypertensive activity than amlodipine (3 mg/kg) and MgT (2 mg/kg).Fig. 2Effect of magnesium taurate on (A) systolic blood pressure and (B) diastolic blood pressure. After monitoring of baseline at day zero animals of Group II to V (toxic control, standard, and MgTs) were treated with CdCl~2~ for two weeks for inducing hypertension thereafter amlodipine and magnesium taurate were administered in their respective group for next two weeks. Values are expressed as mean ± SEM; n = 6 in each; ^a^*P \< 0.05;*^b^*P \< 0.01;*^c^*P \< 0.001* when compared to normal and ^d^*P \< 0.05;*^e^*P \< 0.01;*^f^*P \< 0.001* when compare to toxic control (two-way ANOVA followed by Bonferroni post-hoc test).Fig. 2

3.2. Effect on cardiac antioxidants marker {#sec3.2}
------------------------------------------

[Table 1](#tbl1){ref-type="table"} shows that chronic exposure of CdCl~2~ to the animals of group II to V substantially reduced the myocardial antioxidants like CAT, GPx, GSH, and SOD as compared to the normal group. In CdCl~2~ alone treated rats (toxic control group), the level of antioxidants (CAT, GPx, GSH, and SOD) was significantly (*P \< 0.001*) reduced as compared to the normal group. While CdCl~2~ co-administered with MgT in MgT-treated groups (group IV and V), the level of antioxidants was significantly (*P \< 0.001*), increased as compared to the normal group. The amlodipine-treated rats (standard) also showed significant (*P \< 0.001*) increase in the level of myocardial antioxidants as compared to toxic control group. The results indicate that MgT has similar ability to restore the antioxidants level as that of amlodipine.Table 1Effect of magnesium taurate on CAT, GPx, GSH, SOD, and MDA level in heart.Table 1CAT\
(μmoles of H~2~O~2~ consumed/min/mg protein)GPx\
(μmoles GSH oxidised/min/mg protein)GSH\
(μmoles/g tissue)SOD\
(U/min/mg protein)MDA\
(μmoles/g tissue)Normal33.40 ± 2.082.40 ± 0.076.95 ± 0.109.50 ± 0.545.30 ± 0.25Toxic control11.20 ± 1.06^c^0.94 ± 0.07^c^4.26 ± 0.05^c^3.82 ± 0.21^c^8.48 ± 0.29^c^Standard26.40 ± 1.20^bf^2.10 ± 0.06^bf^6.67 ± 0.11^af^7.34 ± 0.19^cf^6.76 ± 0.26^bf^MgT (2 mg/kg)24.00 ± 1.22^cf^1.59 ± 0.07^cf^5.32 ± 0.11^cf^6.34 ± 0.28^cf^6.74 ± 0.26^bf^MgT (4 mg/kg)26.80 ± 1.28^bf^1.93 ± 0.05^cf^6.37 ± 0.04^cf^8.12 ± 0.28^bf^6.26 ± 0.30^af^[^1]

3.3. Effect on lipid peroxidation {#sec3.3}
---------------------------------

The toxic control group showed significant (*P \< 0.001*) elevation in MDA level as compared to the normal group while MgT and amlodipine-treated groups showed significant (P \< 0.001) depletion in MDA level as compared to toxic control group. The results ([Table 1](#tbl1){ref-type="table"}) indicate that MgT treatments diminish the lipid peroxidation level induced by CdCl~2~ administrations.

3.4. Histopathological studies {#sec3.4}
------------------------------

[Fig. 3](#fig3){ref-type="fig"} shows the results of histopathological examination of the myocardial tissues. The myocardial tissue of normal group showed no pathological changes (score 00) and had the clear integrity of myocardial cell membrane, cardiomyocyte boundary, and cardiac muscle fibers. The CdCl~2~ treatments to the toxic control group led to marked myocardial damages (score 03), it caused loss of cross striation, loss of cardiomyocyte boundary, degeneration in cardiac muscle fibers, necrosis, vacuolization, and fatty degeneration. The amlodipine and MgT (2 mg/kg) treated groups showed moderate degree (score 02) of myocardial damages while MgT at 4 mg/kg dose level showed mild degree (score 01) of myocardial damages. The results indicate that MgT at 4 mg/kg dose level potentially reduces the progression of myocardial damages and has prominent cardioprotective effects than amlodipine and MgT (2 mg/kg).Fig. 3Histopathological section (hematoxylin and eosin stained microscopic sections with 10x and 40x magnification) of heart tissue of the different experimental groups. (A) normal, (B) toxic control, (C) standard, (D) MgT (2 mg/kg), and (E) MgT (4 mg/kg).Fig. 3

4. Discussion {#sec4}
=============

The Cd^2+^, a potent toxicant metal, is widely dispersed in the environment and exposed to the human via industrial contamination, food sources and tobacco smoke.[@bib4] Cd^2+^ exposure can cause a variety of harmful effects in human and animals. It produces toxic effects in several organs, including cardiovascular system.[@bib16], [@bib41] The Cd^2+^ exposure affects the cardiovascular system via several mechanisms. It produces vascular endothelial dysfunction, reduces nitric oxide (NO) level,[@bib15], [@bib16] activates renin-angiotensin system,[@bib13] disrupts Ca^2+^ channel,[@bib5] and induces oxidative stress[@bib14], [@bib33] that cause the induction of hypertension and further exacerbates the cardio toxicity. Therefore, in this study we used CdCl~2~-induced hypertension animal model for inducing hypertension and cardiotoxicity.

In the present investigation, chronic administration of CdCl~2~ to the animals of toxic control group induced significant elevation in systolic and diastolic blood pressure for a consecutive four weeks. Whereas, MgT treatment concurrently with CdCl~2~ from the third week to fourth week significantly reduced the elevated blood pressure suggesting that MgT potentially abolishes the hypertensive effects of CdCl~2~. The anti-hypertensive action of MgT might be due to multiple protective effects of Mg^2+^ and taurine on the cardiovascular system. Mg^2+^ acts as a natural calcium antagonist and regulates the cell membrane function, smooth muscle contraction, vascular endothelial function, and electrolyte homeostasis.[@bib19], [@bib26], [@bib42] Taurine regulates the blood pressure via modulation of vascular endothelial activity, NO level, myocardial cGMP/cAMP ratio, renin-angiotensin system, and antioxidant defense mechanism.[@bib21], [@bib23], [@bib24]

Antioxidant defense system plays a pivotal role in organ protection. Antioxidant enzymes, such as CAT, GPx, and SOD, mitigate the toxic effects of reactive oxygen species (ROS).[@bib43] The SOD catalyzes conversion of superoxide radical and hydrogen peroxide, it also inhibits oxidative inactivation of nitric oxide, consequently preventing peroxynitrite formation and endothelial dysfunction.[@bib44] CAT decomposes the hydrogen peroxide to water and oxygen.[@bib45] GPx regulates the hydrogen peroxide content within the cell.[@bib46] Thus, antioxidant enzymes protect organ damage from oxidative stress. The disruption of antioxidant defense system elevates the ROS/antioxidant ratio in oxidative stress condition that is responsible for the oxidation of cellular proteins and lipids, resulting in oxidative organ damage.[@bib47] The CdCl~2~ administration significantly reduced the enzymatic antioxidants (CAT, GPx, and SOD) level in the toxic control myocardial tissues. However, MgT treatment significantly restored these antioxidants, suggesting that MgT prevents oxidative damage of myocardial tissues against CdCl~2~ exposure. The restoration of antioxidant defense system by MgT may be attributed to potent antioxidant ability of Mg^2+^ and taurine, which was corroborated with various researchers.[@bib24], [@bib26], [@bib48], [@bib49]

In addition, MgT treatment significantly enhanced the GSH level (non-enzymatic antioxidants) and reduced MDA level (an end product of lipid peroxidation) in myocardial tissues of MgT-treated group as compared to toxic control group. The histopathological studies also indicate the restoration of damage caused by CdCl~2~ after treatment with MgT. The increased GSH and decreased MDA level can be attributed to the protective effects of MgT against CdCl~2~-induced oxidative cellular damage. GSH is a major intracellular non-protein --SH compound that plays an important role in protecting cells against electrophiles and free radicals. GSH maintains cell membrane protein --SH groups in the reduced form, and scavenges free radical by neutralizing hydroxyl ion.[@bib47] MDA is generated by peroxidation of polyunsaturated fatty acids that can be accelerated by ROS. MDA may further react with proteins, phospholipids, and nucleic acid leading to structural modifications.[@bib47], [@bib50] The myocardial protection shown by MgT might have been mediated via restoration of basal myocardial antioxidants enzyme activities.

Thus, we can conclude that MgT alleviates the cardiovascular protection by restoring hypertension and myocardial antioxidant defense system. The results suggest that MgT can be used as a nutritional supplement to manage cardiovascular complications.
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[^1]: Values are expressed as mean ± SEM; n = 6 in each; ^a^*P \< 0.05;*^b^*P \< 0.01;*^c^*P \< 0.001* when compared to normal and ^d^*P \< 0.05;*^e^*P \< 0.01;*^f^*P \< 0.001* when compare to toxic control (one-way ANOVA followed by Newman Keuls post hoc test). CAT: catalase; GPx: glutathione peroxidase; GSH: reduced glutathione; SOD: superoxide dismutase; MDA: malondialdehyde.
